DJIA 17,428.69 41.48 0.24%
NASDAQ 4,694.50 13.00 0.28%
S&P 500 2,030.28 0.73 0.04%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

7.42 -0.03 (-0.40%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VSTM $7.42 -0.40%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.49
Previous Close $7.45
Daily Range $7.26 - $7.64
52-Week Range $6.87 - $16.60
Market Cap $192.1M
P/E Ratio -3.74
Dividend (Yield) $0.00 (0.0%)
Volume 183,769
Average Daily Volume 524,494
Current FY EPS -$2.09

Sector

Healthcare

Industry

Drugs

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website: http://www.verastem.com/

News & Commentary Rss Feed

Verastem Inc.'s Upcoming Catalysts

Verastem might have to compete with GlaxoSmithKine, but Eli Lilly won't be a problem since it's targeting patients that have already taken Lilly's drug.

3 Biotech IPOs Debuting This Week

5 Biotech Secondaries Traders Are Watching

US Stock Futures Surge Ahead Of Earnings

Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-606

Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-6063 in Mesothelioma

Monday 12/29 Insider Buying Report: VSTM

VSTM: Insiders Vs. Shorts

Verastem To Participate In Panel At The MassBio Patient Advocacy Summit

Verastem (VSTM) Shows Strength: Stock Adds 7% in Session - Tale of the Tape

Verastem (VSTM) Crumbles: Stock Falls by 6.1% - Tale of the Tape

See More VSTM News...